Related Experiment Video
Updated: Apr 26, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Alect2 amyloidosis: primum non nocere (first, do no harm)
1Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA.
Abstract:
Said et al. and Larsen et al. present the clinical, morphologic, and genetic features of a recently described amyloidosis, derived from leukocyte chemotactic factor 2 (Alect2), which is beginning to be recognized as an important cause of end-stage renal disease in Hispanics. While the etiology of Alect2 is unknown, and there is currently no effective treatment, it is important to avoid misdiagnosing it as the more common AL, and applying harmful treatment in consequence.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer Disease l: Introduction
Cross-bridge Cycle
Myasthenia Gravis ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology

